iSpecimen Inc. (NASDAQ:ISPC) Shares Shorted: Short Interest Up 92.3% in October

iSpecimen Inc. (NASDAQ:ISPC – Get Free Report) saw a significant increase in short interest in October. As of October 30th, there was short interest totaling 305,211 shares, an increase of 92.3% from the October 15th total of 158,754 shares. Based on an average daily volume of 412,744 shares, the days-to-cover ratio is presently 0.7 days. Approximately 13.8% of the company’s shares are short sold.

iSpecimen Trading Down 8.2%

Shares of NASDAQ:ISPC traded down $0.05 during trading on Monday, hitting $0.60. 64,770 shares of the company’s stock traded hands, compared to its average volume of 305,883. iSpecimen has a 52 week low of $0.57 and a 52 week high of $27.44. The company has a market cap of $1.52 million, a price-to-earnings ratio of -0.01 and a beta of 1.54. The company has a 50-day moving average price of $1.05 and a 200-day moving average price of $4.19.

iSpecimen (NASDAQ:ISPC – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.98) earnings per share for the quarter. iSpecimen had a negative net margin of 2,445.40% and a negative return on equity of 524.39%. The company had revenue of $0.15 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of iSpecimen from a “sell (e)” rating to a “sell (e+)” rating in a research report on Thursday, October 29th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Check Out Our Latest Stock Report on ISPC

About iSpecimen

(Get Free Report)

iSpecimen, Inc. operates an online marketplace that connects life-science researchers with hospitals, laboratories, biobanks and other providers of human biospecimens. Its platform is designed to help researchers find and request samples for medical and scientific research. Through its iSpecimen Marketplace, the company facilitates access to materials such as blood, tissue and other human specimens, along with associated data when available. It also supports the coordination of specimen sourcing and fulfillment between research organizations and providers.

Further Reading

Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.